Clarification on the observations of the unexpected positive effects of Foxy-5 in colon cancer
As previously announced by the company, the ad hoc analysis has shown that Foxy-5 treated patients in the NeoFox study have statistically significant TNM downstaging compared to patients in the control arm. This press release intends to provide more details.The ad hoc analysis shows a statistically significant difference between the control arm and Foxy-5 treated colon cancer patients with respect to three prognostic parameters at surgery i.e. after only three weeks of treatment. The most important prognostic analysis in colon cancer is the so-called TNM grading (Staging according to the